Is an eosinophil count of 0.2 × 10⁹/L (≈200 cells/µL) within the normal range and does it require further evaluation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

An eosinophil count of 0.2 × 10⁹/L is below the normal range and does not require investigation for eosinophilia-related conditions.

Normal Range and Definition

Your eosinophil count of 0.2 × 10⁹/L falls below the lower threshold for eosinophilia, which is defined as > 0.5 × 10⁹/L 1. This value is actually at the lower end of the normal spectrum, as the median eosinophil count in non-asthmatic populations is approximately 0.15-0.16 × 10⁹/L 2, 3.

Clinical Significance

  • No concern for helminth infections or allergic conditions: The UK guidelines specifically define eosinophilia as requiring a count > 0.5 × 10⁹/L before any investigation for parasitic infections, allergic diseases, or other eosinophil-related conditions is warranted 1

  • No hematology referral needed: Recent evidence suggests that hematology referral should be considered only when eosinophil counts reach ≥ 1.5 × 10⁹/L, particularly in asymptomatic patients 4. Your count is far below this threshold.

  • No risk of end-organ damage: Persistent eosinophilia causing end-organ damage (heart, lungs, central nervous system) occurs with sustained elevations, particularly ≥ 1.5 × 10⁹/L for more than 3 months 1. Your low count carries no such risk.

Important Caveat About Low Counts

While your count doesn't indicate eosinophilia, research has identified a U-shaped risk pattern where very low eosinophil counts (approaching zero) may paradoxically associate with certain conditions 3, 5. However, at 0.2 × 10⁹/L, you remain within the normal range and this concern is not applicable.

Bottom line: No further evaluation or treatment is needed for this eosinophil level unless you develop specific symptoms suggesting allergic disease, parasitic infection, or other systemic conditions—and even then, the investigation would be symptom-driven, not eosinophil-driven.

Related Questions

What is the recommended further testing and treatment for a patient with a peripheral eosinophil percentage of 15.3% on a complete blood count differential?
What are the possible causes of an isolated very low eosinophil count in an asymptomatic patient referred to a hematology‑oncology specialist?
How should I evaluate and manage an isolated eosinophil count of 0.40 ×10⁹/L (normal cutoff 0.20 ×10⁹/L) with an otherwise normal complete blood count?
How should I evaluate and manage a 22-year-old patient with an absolute eosinophil count of 614 cells/µL?
What is the appropriate evaluation and management for a patient with elevated eosinophils, neutrophils, and monocytes on a complete blood count?
What is the appropriate clomiphene citrate regimen, monitoring schedule, and contraindications for inducing ovulation in an adult woman of reproductive age with documented low basal follicle‑stimulating hormone (FSH) and luteinizing hormone (LH) consistent with hypogonadotropic hypogonadism?
Is it safe to start hydroxyzine and escitalopram (Lexapro) together for severe anxiety?
What is the recommended topical therapy for a small (≤2 cm) superficial basal cell carcinoma located on a low‑tension area in a patient who prefers a non‑surgical approach?
How should I manage a patient with elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT) who is on long‑term antibiotic therapy?
In a hemodialysis patient with persistently elevated serum phosphorus despite calcium acetate therapy, normal serum calcium, and markedly increased intact parathyroid hormone, what is the likely cause, which non‑calcium phosphate binder and dose should be used, and is tenapanor an appropriate option for management?
In a female patient with years of severe knee pain, popping/twisting on standing, hyperesthesia, swelling, instability, normal MRI of the spine, hip, and knee, and a sensation of a floating patella (patellar alta), what are the next appropriate diagnostic and management steps?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.